KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34,000 | $590,580 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 10,608 | $184,261 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 3,502 | $60 | 0.00% |
| Parallel Advisors, LLC | 679 | $11,794 | 0.00% |
| FRANKLIN RESOURCES INC | 26,652 | $462,946 | 0.00% |
| Legal & General Group Plc | 24,124 | $419,033 | 0.00% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 78,042 | $1,355,590 | 0.00% |
External links
This page lists KINIKSA PHARMACEUTICALS LTD's shareholders in Q3 2023. To view KINIKSA PHARMACEUTICALS LTD's shareholder history, click here.